PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
16.31%
Revenue growth exceeding 1.5x AVGO's 6.80%. David Dodd would verify if faster growth reflects superior business model.
-17.49%
Cost reduction while AVGO shows 1.77% growth. Joel Greenblatt would examine competitive advantage.
149.98%
Gross profit growth exceeding 1.5x AVGO's 12.88%. David Dodd would verify competitive advantages.
114.92%
Margin expansion exceeding 1.5x AVGO's 5.69%. David Dodd would verify competitive advantages.
2.64%
R&D growth above 1.5x AVGO's 1.43%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.41%
Operating expenses growth above 1.5x AVGO's 2.42%. Michael Burry would check for inefficiency.
-10.29%
Total costs reduction while AVGO shows 1.97% growth. Joel Greenblatt would examine advantage.
-5.80%
Interest expense reduction while AVGO shows 0.00% growth. Joel Greenblatt would examine advantage.
-1.12%
D&A reduction while AVGO shows 0.00% growth. Joel Greenblatt would examine efficiency.
277.42%
EBITDA growth exceeding 1.5x AVGO's 17.45%. David Dodd would verify competitive advantages.
182.36%
EBITDA margin growth exceeding 1.5x AVGO's 10.60%. David Dodd would verify competitive advantages.
197.95%
Operating income growth exceeding 1.5x AVGO's 25.00%. David Dodd would verify competitive advantages.
184.21%
Operating margin growth exceeding 1.5x AVGO's 17.05%. David Dodd would verify competitive advantages.
-21.42%
Other expenses reduction while AVGO shows 11.11% growth. Joel Greenblatt would examine advantage.
202.90%
Pre-tax income growth exceeding 1.5x AVGO's 28.28%. David Dodd would verify competitive advantages.
188.47%
Pre-tax margin growth exceeding 1.5x AVGO's 20.12%. David Dodd would verify competitive advantages.
246.19%
Tax expense growth while AVGO reduces burden. John Neff would investigate differences.
202.16%
Net income growth exceeding 1.5x AVGO's 36.67%. David Dodd would verify competitive advantages.
187.83%
Net margin growth exceeding 1.5x AVGO's 27.97%. David Dodd would verify competitive advantages.
204.17%
EPS growth exceeding 1.5x AVGO's 34.21%. David Dodd would verify competitive advantages.
200.00%
Diluted EPS growth exceeding 1.5x AVGO's 35.14%. David Dodd would verify competitive advantages.
0.85%
Share count reduction below 50% of AVGO's 0.42%. Michael Burry would check for concerns.
5.08%
Diluted share reduction below 50% of AVGO's 0.41%. Michael Burry would check for concerns.